TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $2,000 | -33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,000 | +50.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | -33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | 0.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | 0.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,000 | -57.1% | 33 | -50.0% | 0.00% | -50.0% |
| Q3 2017 | $7,000 | +75.0% | 66 | +100.0% | 0.00% | +100.0% |
| Q2 2017 | $4,000 | 0.0% | 33 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $4,000 | -20.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | 0.0% | 33 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $5,000 | -64.3% | 33 | -64.5% | 0.00% | -62.5% |
| Q4 2015 | $14,000 | +7.7% | 93 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $13,000 | +44.4% | 93 | +55.0% | 0.01% | +33.3% |
| Q2 2015 | $9,000 | -30.8% | 60 | -35.5% | 0.01% | -25.0% |
| Q1 2015 | $13,000 | -7.1% | 93 | 0.0% | 0.01% | -20.0% |
| Q4 2014 | $14,000 | 0.0% | 93 | 0.0% | 0.01% | -9.1% |
| Q3 2014 | $14,000 | -26.3% | 93 | -30.1% | 0.01% | -26.7% |
| Q2 2014 | $19,000 | +26.7% | 133 | 0.0% | 0.02% | +15.4% |
| Q1 2014 | $15,000 | +15.4% | 133 | 0.0% | 0.01% | +18.2% |
| Q4 2013 | $13,000 | +62.5% | 133 | +33.0% | 0.01% | +37.5% |
| Q3 2013 | $8,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |